Vutrisiran Reduces Neurologic Damage, Improves Physical Function, Trial Data Show
News
Vutrisiran, a second-generation RNA interference (RNAi) therapy candidate, safely and effectively reduces neurologic impairment and improves physical function and quality of life in adults with familial amyloid polyneuropathy (FAP). ... Read more